Glipizide Tablet, Film Coated, Extended Release
Product Images NDC 70518-1848

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 70518-1848). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glipizide 10mg 70518 1848 00

This is a bottle of 90 extended-release glipizide tablets, each containing 10 mg of the medication. It is manufactured by Rising Pharma, Inc. in Allendale, NJ, with a source NDC number of 64980-0281-05. The repackaging was done by RemedyRepack Inc. in Indiana, PA. The NDC number for the packaged product is 70518-1848-00. The label provides storage instructions, expiration date and encourages keeping the medication out of the reach of children. Directions for use are found in the package insert.*

FDA Label Image

Glipizide 10mg 70518 1848 01

This is a description of a medication named "glipiZIDE." It is an extended-release tablet with a dosage of 10 mg. The package contains 30 tablets with NDC number 70518-1848-01. The manufacturer is Rising Pharma, Inc., located in Allendale, NJ 07401. The medication should be kept out of the reach of children, and the directions for use are provided in the package insert. The medication should be stored at a temperature range of 20-26°C (63-77°F), with permitted excursions to 15-30°C (59-86°F) as per USP standards. The medication has been repackaged by RemedyRepack Inc., located in Indiana, PA 15701.*

FDA Label Image

Structural Formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.